Teriflunomide
Teriflunomide | CAS NO: 163451-81-8, Teriflunomide is an oral immunomodulatory drug primarily used in the treatment of multiple sclerosis (MS). Below are its key uses and indications: Relapsing forms of Multiple Sclerosis (MS)
We are the Synchemia Research Chemical specializes in manufactures (EP/BP/USP/IP) as well as process-related impurities Teriflunomide is approved for the treatment of relapsing forms of MS, including: Clinically Isolated Syndrome (CIS) Relapsing-Remitting MS (RRMS), Active Secondary Progressive MS. Buy Reliable and High-Purity Teriflunomide Impurities, Delivered by Synchemia Research Chemicals.
Pharmaceutical Reference Standards
| CAT No | SRC-T46221 |
| CAS No | 163451-81-8 |
| Mol.F. | C12H9F3N2O2 |
| Mol.Wt. | 270.2 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-T46222 |
| CAS No | 455-14-1 |
| Mol.F. | C7H6F3N |
| Mol.Wt. | 161.1 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-T46223 |
| CAS No | 24522-30-3 |
| Mol.F. | C10H7F3N2O |
| Mol.Wt. | 228.2 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-T46224 |
| CAS No | 202057-74-7 |
| Mol.F. | C12H9N3O2 |
| Mol.Wt. | 227.2 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-T46225 |
| CAS No | 208401-20-1 |
| Mol.F. | C12H9F3N2O2 |
| Mol.Wt. | 270.2 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-T46226 |
| CAS No | 69066-42-8 |
| Mol.F. | C9H6F3NO3 |
| Mol.Wt. | 233.2 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-T46227 |
| CAS No | 1011244-72-6 |
| Mol.F. | C14H11F3N2O |
| Mol.Wt. | 280.3 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-T46228 |
| CAS No | 2366-92-9 |
| Mol.F. | C9H9F3O |
| Mol.Wt. | 190.2 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-T46229 |
| CAS No | 1980063-54-4 |
| Mol.F. | C7H7F2N : HCl |
| Mol.Wt. | 143.1 : 36.5 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-T46230 |
| CAS No | 724429-16-7 |
| Mol.F. | C12H12N2O2 |
| Mol.Wt. | 216.2 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-T46231 |
| CAS No | 106-49-0 |
| Mol.F. | C7H9N |
| Mol.Wt. | 107.2 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-T46232 |
| CAS No | 61865-29-0 |
| Mol.F. | C7H8FN |
| Mol.Wt. | 125.2 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-T46233 |
| CAS No | 3788-94-1 |
| Mol.F. | C9H14O4 |
| Mol.Wt. | 186.2 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-T46234 |
| CAS No | 39885-50-2 |
| Mol.F. | C7H5ClF3N |
| Mol.Wt. | 195.6 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-T46235 |
| CAS No | 75706-12-6 |
| Mol.F. | C12H9F3N2O2 |
| Mol.Wt. | 270.2 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-T46236 |
| CAS No | 171171-44-1 |
| Mol.F. | C8H6F3NO2 |
| Mol.Wt. | 205.1 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
Let’s advance your research together.
Partner with us for specialized chemical materials and synthesis services that enable pharmaceutical innovation.